Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication
Author(s) -
François Danion,
Valérie LetscherBru,
J. Guitard,
Karine Sitbon,
Sarah Dellière,
A. Angoulvant,
Guillaume Désoubeaux,
Françoise Botterel,
AnnePauline Bellanger,
Gilles Gargala,
Fabrice Uhel,
MarieElisabeth Bougnoux,
V. Gerber,
Justin Michel,
Marjorie Cornu,
Stéphane Bretagne,
Fanny Lanternier,
Hamid Merdji,
Xavier Delabranche,
Antoine Parrot,
Guillaume Voiriot,
Tomas Urbina,
Alexandre Mebazaa,
Benjamin G. Chousterman,
Ahmed El Kalioubie,
Sophie Six,
Pauline Coulon,
Boualem Sendid,
Nadia Anguel,
Charles Damoisel,
Charlotte Mussini,
Alban Villate,
Jean-Christophe Navellou,
Christophe Girault,
Carole Cassagne,
Olivier Augereau,
Françoise Dromer,
Dea García-Hermoso,
Olivier Lortholary,
Alexandre Alanio
Publication year - 2021
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofab566
Subject(s) - mucormycosis , medicine , complication , diabetes mellitus , covid-19 , disease , dermatology , surgery , infectious disease (medical specialty) , endocrinology
We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus up to 95% in India), hematological malignancies (35% versus 1%), anatomical sites (12% versus >80% rhino-orbito-cerebral) and prognosis (88% mortality versus <50%).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom